SurModics Inc (SRDX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SurModics Inc (SRDX) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.41 Million) by net assets ($111.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SurModics Inc - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how SurModics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of SurModics Inc for a breakdown of total debt and financial obligations.
SurModics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SurModics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Morn Electric Equipment Co Ltd
SHE:002451
|
-0.140x |
|
Cheng Loong Corp
TW:1904
|
0.038x |
|
Hangzhou CNCR-IT Co Ltd
SHE:300250
|
0.018x |
|
Jinlong Machinery Electronic
SHE:300032
|
0.073x |
|
Changzhou Xiangming Intelligent Drive System Corporation
SHE:301226
|
N/A |
|
Guangdong Qunxing Toys Joint-Stock Co Ltd
SHE:002575
|
0.008x |
|
MarineMax Inc
NYSE:HZO
|
0.018x |
|
Haixia Envrnmnt
SHG:603817
|
0.016x |
Annual Cash Flow Conversion Efficiency for SurModics Inc (1998–2024)
The table below shows the annual cash flow conversion efficiency of SurModics Inc from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see SurModics Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | $118.90 Million | $248.00K | 0.002x | -97.62% |
| 2023-09-30 | $119.91 Million | $10.51 Million | 0.088x | +155.18% |
| 2022-09-30 | $108.39 Million | $-17.22 Million | -0.159x | -244.64% |
| 2021-09-30 | $140.09 Million | $15.39 Million | 0.110x | +2.76% |
| 2020-09-30 | $131.06 Million | $14.01 Million | 0.107x | +62.94% |
| 2019-09-30 | $122.52 Million | $8.04 Million | 0.066x | -79.07% |
| 2018-09-30 | $108.61 Million | $34.05 Million | 0.314x | +148.89% |
| 2017-09-30 | $111.56 Million | $14.05 Million | 0.126x | -46.52% |
| 2016-09-30 | $106.83 Million | $25.17 Million | 0.236x | +46.43% |
| 2015-09-30 | $93.37 Million | $15.02 Million | 0.161x | -12.64% |
| 2014-09-30 | $98.75 Million | $18.18 Million | 0.184x | -2.20% |
| 2013-09-30 | $93.82 Million | $17.66 Million | 0.188x | +10.66% |
| 2012-09-30 | $94.69 Million | $16.11 Million | 0.170x | +23.92% |
| 2011-09-30 | $145.34 Million | $19.95 Million | 0.137x | -3.70% |
| 2010-09-30 | $154.36 Million | $22.01 Million | 0.143x | -21.53% |
| 2009-09-30 | $172.37 Million | $31.32 Million | 0.182x | -35.29% |
| 2008-09-30 | $141.81 Million | $39.82 Million | 0.281x | -27.50% |
| 2007-09-30 | $130.92 Million | $50.71 Million | 0.387x | +59.43% |
| 2006-09-30 | $145.20 Million | $35.28 Million | 0.243x | +8.22% |
| 2005-09-30 | $115.58 Million | $25.95 Million | 0.225x | +8.85% |
| 2004-09-30 | $94.50 Million | $19.49 Million | 0.206x | -7.77% |
| 2003-09-30 | $86.11 Million | $19.26 Million | 0.224x | +9.36% |
| 2002-09-30 | $70.00 Million | $14.31 Million | 0.204x | +45.82% |
| 2001-09-30 | $55.70 Million | $7.81 Million | 0.140x | -8.18% |
| 2000-09-30 | $48.30 Million | $7.38 Million | 0.153x | +3.09% |
| 1999-09-30 | $29.70 Million | $4.40 Million | 0.148x | +60.14% |
| 1998-09-30 | $22.70 Million | $2.10 Million | 0.093x | -- |
About SurModics Inc
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision o… Read more